Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/1995
09/29/1995CA2145579A1 Eva-based transdermal matrix system for the administration of an oestrogen and/or a progestogen
09/28/1995WO1995025809A1 Compacted nucleic acids and their delivery to cells
09/28/1995WO1995025808A1 Process for treating eucaryotic cells
09/28/1995WO1995025805A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
09/28/1995WO1995025804A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)
09/28/1995WO1995025803A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF)
09/28/1995WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β)
09/28/1995WO1995025764A1 Double-stranded derivative of polyoxyethylene-containing lipid
09/28/1995WO1995025763A1 Branched polyoxaalkyl macromolecules, process for making them and their uses
09/28/1995WO1995025546A1 Dispensing unit containing a particulate product for the administration of drugs or nutrient preparations to animals and process for the manufacture of the particulate product
09/28/1995WO1995025545A1 The use of dimeticone as a transport and carrier system and/or drug delivery system
09/28/1995WO1995025544A1 Gel for treatment of skin diseases and for disinfection of the skin
09/28/1995WO1995025534A1 Stabilized composition for oral administration of peptides
09/28/1995WO1995025523A1 Novel pharmaceutical composition for skin diseases
09/28/1995WO1995025516A1 Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant
09/28/1995WO1995025513A1 Zinc compound and cyclodextrine for treatment of gastric disorders
09/28/1995WO1995025507A1 Retinal-containing composition
09/28/1995WO1995025505A1 Hydrophobic drug delivery systems
09/28/1995WO1995025504A1 Emulsified drug delivery systems
09/28/1995WO1995025502A1 Polyglycerine polyricinoleates
09/28/1995WO1995023586A3 Cosmetic and/or pharmaceutical preparations
09/28/1995DE19510551A1 Oral insulin prepns resistant to proteolytic enzymes
09/28/1995CA2186045A1 Gel for treatment of skin diseases and for disinfection of the skin
09/28/1995CA2185882A1 The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases
09/28/1995CA2185647A1 Branched polyoxaalkyl macromolecules, process for making them and their uses
09/28/1995CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf)
09/28/1995CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.)
09/28/1995CA2184200A1 Recombinant viruses, preparation and use in genic therapy
09/28/1995CA2183647A1 Process for treating eucaryotic cells
09/27/1995EP0673649A1 Pharmaceutical compositions for the prolonged release of trimetazidine after oral administration
09/27/1995EP0673648A1 Compositions comprising amphotoic salts of alpha-hydroxy acids and glycerol monocaprylate
09/27/1995EP0673259A1 A method for transplanting cells into the brain and therapeutic uses therefor
09/27/1995EP0673258A1 Polymer-bound camptothecin derivatives
09/27/1995EP0673245A1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same.
09/27/1995EP0673240A1 Stabilized medicinal aerosol solution formulations
09/27/1995EP0673199A1 Stabilized lanthionine bacteriocin compositions
09/27/1995EP0578768B1 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
09/27/1995EP0261225B1 Lectin complex and method and probe for making same
09/27/1995CN1108968A Use of ion exchange resins loaded with quioolonecarboxylic acid derivatives
09/27/1995CN1108931A Rapamycin formulations for oral administration
09/27/1995CN1108927A Silica ketoconazole ointment and its preparation
09/26/1995US5453447 Preparation of stable injectable β-carotene solubilizates
09/26/1995US5453425 Risperidone oral formulation
09/26/1995US5453373 Protein C derivatives
09/26/1995US5453359 Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
09/26/1995US5453283 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
09/26/1995US5453279 Enhancing transdermal absorption compositions; transdermal dosage form; and process
09/23/1995CA2142940A1 Method and composition having enhanced alpha-hydroxy skin permeation and retention
09/22/1995EP0681572A4 Cyclic imide thione activated polyalkylene oxides.
09/21/1995WO1995025122A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
09/21/1995WO1995025121A1 Enhancement of antitumor therapy with hemoglobin-based conjugates
09/21/1995WO1995025119A1 Stabilization of peptides and proteins for radiopharmaceutical use
09/21/1995WO1995025084A1 A method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes
09/21/1995WO1995024930A1 Use of green porphyrins in ocular diagnosis and therapy
09/21/1995WO1995024928A2 Heparin-binding growth factors for gene therapy and anterior eye disorders
09/21/1995WO1995024923A2 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
09/21/1995WO1995024908A1 Use of nitric oxide-releasing polymers to treat restenosis and related disorders
09/21/1995WO1995024898A1 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
09/21/1995WO1995024893A1 Delivery systems for hydrophobic drugs
09/21/1995WO1995024892A1 Aerosol drug formulations containing vitamin e
09/21/1995WO1995024891A1 Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions
09/21/1995WO1995024890A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide
09/21/1995WO1995022974A3 Film coated tablet of paracetamol and domperidone
09/21/1995DE4410637C1 Injizierbare Lösungen von Dirithromycin Injectable solutions of dirithromycin
09/21/1995DE4409357A1 Verwendung von Dimeticon zur Behandlung von Helicobacter Pylori-assoziierten Erkrankungen Use of dimethicone for the treatment of Helicobacter pylori associated diseases
09/21/1995CA2185690A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide
09/21/1995CA2185671A1 Heparin-binding growth factors for gene therapy and anterior eye disorders
09/21/1995CA2185651A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
09/21/1995CA2185433A1 Enhancement of antitumor therapy with hemoglobin-based conjugates
09/21/1995CA2184753A1 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
09/21/1995CA2183557A1 Aerosol drug formulations containing vitamin e
09/20/1995EP0672682A1 hPTH(1-36) peptides, their preparation and pharmaceutical compositions
09/20/1995EP0672677A2 Polyamide-oligonucleotide derivatives, their production and use
09/20/1995EP0672422A1 Antiinflammatory and analgesic transdermal gel
09/20/1995EP0672414A2 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
09/20/1995EP0672410A1 Silicon vesicles and entrapment
09/20/1995EP0672253A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor
09/20/1995EP0672076A1 Use of cationic polyurethanes and polycarbamides as auxiliary substances in cosmetic and pharmaceutical compositions.
09/20/1995EP0672061A1 Receptor for oncostatin m and leukemia inhibitory factor
09/20/1995EP0672053A1 Treatment of septic shock with conjugated biologically active peptides
09/20/1995EP0671942A1 Medical use, a medical method and a pharmaceutical preparation
09/20/1995EP0671937A1 Pharmaceutical emulsion compositions
09/20/1995EP0671936A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-$g(a) FUNCTION
09/20/1995EP0671929A1 Compositions
09/20/1995EP0671919A1 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it
09/20/1995EP0671916A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer
09/20/1995EP0671912A1 Injectable taxane derivative based compositions
09/20/1995EP0671908A1 Pharmaceutical compositions comprising 5-ht 1? receptor agonists and absorption enhancers
09/20/1995EP0671906A1 Bioadhesive microspheres and their use as drug delivery and imaging systems
09/20/1995EP0671905A1 Stable protein: phospholipid compositions and methods
09/20/1995EP0671904A1 Antibiotic formulation and use for drug resistant infections
09/20/1995EP0671903A1 Topical and transdermal delivery system utilizing submicron oil spheres
09/20/1995EP0620731B1 Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it
09/20/1995EP0584315B1 Cosmetic and/or pharmaceutical composition containing a dispersion of lipidic vesicles, process for the preparation of said dispersion, and lipidic vesicle dispersion
09/20/1995EP0565620B1 Mitotoxin for treatment of vascular injury
09/20/1995EP0536343B1 Targeted polymeric conjugates of cyclosporin and method for their preparation
09/20/1995EP0448635B1 Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
09/20/1995EP0429644B1 Chelating agents for attaching metal ions to proteins
09/20/1995CN1108529A Rapamycin formulations for oral administration
09/20/1995CN1029770C Controlled release bases for pharmaceuticals